Targeted nanoliposomal nutrient delivery for human health

Table 1 Comparative analysis of conventional oral supplements and nanoliposomal delivery systems

Aspect	Conventional oral supplements	Nanoliposomal delivery systems
Gastric stability	Low: Vulnerable to acidic pH and enzymatic degradation	High: Encapsulation within phospholipid bilayers confers protection against gastric acid and enzymatic hydrolysis
Intestinal absorption	Limited: Constrained by poor solubility and epithelial permeability	Enhanced: Improved solubility and interaction with enterocyte uptake mechanisms (e.g., endocytosis)
First-pass metabolism	Pronounced: Hepatic metabolism via portal vein reduces bioactivity	Attenuated: Lymphatic transport via chylomicrons partially circumvents hepatic first-pass metabolism
Systemic distribution	Non-specific: Diffuse dilution across systemic tissues	Targeted: Surface ligands enable receptor-mediated delivery to specific tissues
Bioavailability	Suboptimal: High doses required to achieve therapeutic levels	Superior: Increased efficiency permits lower effective doses
Therapeutic index	Variable: Elevated doses may precipitate gastrointestinal adverse effects	Optimized: Targeted delivery enhances efficacy while minimizing off-target toxicity

Conventional oral supplement absorption: Depicts the degradation of an ingested supplement in the acidic stomach environment (pH approximately 1.0-2.0), followed by enzymatic breakdown in the intestinal lumen. A minor fraction traverses the intestinal epithelium into the portal circulation, undergoing substantial first-pass metabolism in the liver, resulting in diminished systemic bioavailability. Nanoliposomal nutrient delivery: Illustrates a nanoliposome-encapsulated nutrient resisting gastric degradation due to its protective lipid bilayer. Upon reaching the small intestine, the liposome is absorbed via enterocytes or lymphatic pathways (e.g., chylomicron-mediated transport), partially bypassing hepatic metabolism. Functionalized ligands on the liposome surface facilitate receptor-mediated endocytosis into target tissues, with subsequent endosomal escape mechanisms ensuring cytosolic delivery. This culminates in elevated bioavailability and concentrated nutrient deposition at intended sites.